Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
33%
ALSO IN CANC
CANC
53
HOLDINGS
27%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.5% | 4.8% | 4.8% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.5% | 4.2% | 4.2% |
|
MERCK & CO. INC. | 4.3% | 3.6% | 3.6% |
 |
ASTRAZENECA PLC | 4.0% | 3.5% | 3.5% |
|
NOVARTIS AG | 3.4% | 4.1% | 3.4% |
HRTS Overweight Relative to CANC
|
ELI LILLY & CO | 6.7% |
|
UNITEDHEALTH GROUP INC | 5.2% |
 |
NOVO NORDISK A/S-B | 5.2% |
|
THERMO FISHER SCIENTIFIC INC | 4.0% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
|
DANAHER CORP | 2.7% |
|
ABBOTT LABORATORIES | 2.6% |
|
CYTOKINETICS INC | 2.5% |
|
GILEAD SCIENCES INC | 2.3% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.1% |
HRTS Underweight Relative to CANC
|
COGENT BIOSCIENCES INC | -4.1% |
|
IMMUNOME, INC. | -3.9% |
|
REVOLUTION MEDICINES, INC. | -3.8% |
|
CELCUITY INC. | -3.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.5% |
|
NUVALENT, INC. CLASS A | -3.4% |
|
EXELIXIS INC | -2.8% |
|
CG ONCOLOGY, INC. | -2.4% |
|
GENMAB A/S SPONSORED ADR | -2.4% |
|
IDEAYA BIOSCIENCES, INC. | -2.3% |